These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16142801)

  • 1. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes.
    Arakawa T; Yu J; Chong DK; Hough J; Engen PC; Langridge WH
    Nat Biotechnol; 1998 Oct; 16(10):934-8. PubMed ID: 9788349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.
    Yuki Y; Byun Y; Fujita M; Izutani W; Suzuki T; Udaka S; Fujihashi K; McGhee JR; Kiyono H
    Biotechnol Bioeng; 2001 Jul; 74(1):62-9. PubMed ID: 11353411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
    Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
    Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.
    Arêas AP; Oliveira ML; Miyaji EN; Leite LC; Aires KA; Dias WO; Ho PL
    Biochem Biophys Res Commun; 2004 Aug; 321(1):192-6. PubMed ID: 15358234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.
    Urbanek-Ruiz I; Ruiz PJ; Paragas V; Garren H; Steinman L; Fathman CG
    Clin Immunol; 2001 Aug; 100(2):164-71. PubMed ID: 11465945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
    Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M
    Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.
    Tarkowski A; Sun JB; Holmdahl R; Holmgren J; Czerkinsky C
    Arthritis Rheum; 1999 Aug; 42(8):1628-34. PubMed ID: 10446861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].
    Liu X; Yang G; Qiu B; Tian P
    Wei Sheng Wu Xue Bao; 2001 Oct; 41(5):625-9. PubMed ID: 12552813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
    Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.
    Song H; Zhou L; Fang W; Li Y; Wang X; Fang H; Li X; Wu M; Qiu B
    Biochem Biophys Res Commun; 2004 Feb; 315(1):235-9. PubMed ID: 15013451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit.
    Bäckström M; Lebens M; Schödel F; Holmgren J
    Gene; 1994 Nov; 149(2):211-7. PubMed ID: 7525413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A fusion protein of rotavirus VP6 and cholera toxin B subunit: expression in Escherichia coli and analysis of biological activities].
    Guo TX; Fang RX; Li GH; Qian Y
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):621-5. PubMed ID: 11910752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of protective immune response in mice and rhesus monkeys by immunization with fusion protein of cholera toxin B subunit and multiples of Plasmodium falciparum].
    Cao C; Li P; Shi CH; Zhong H; Li JZ; Shi YL; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2000 May; 16(3):333-6. PubMed ID: 11059275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.